Extracellular Vesicles as Stroke Biomarkers

CompletedOBSERVATIONAL
Enrollment

88

Participants

Timeline

Start Date

June 25, 2018

Primary Completion Date

September 30, 2022

Study Completion Date

July 31, 2023

Conditions
StrokeRehabilitation
Interventions
OTHER

blood withdrawal

"10 ml of blood, two 5 ml tubes suitable for serum isolation. Given the nature and objectives of the study, there are no risks and / o inconveniences of particular importance for the patient since the blood samples will be performed according to the common procedure used in all analysis laboratories. At the end of the collection, in the area where the blood sample was taken, a small bruise may form which will disappear in the following hours, in any case during the collection particular attention will be paid to the subjects being treated with antiplatelet and anticoagulants.~The study does not include the execution of interventional treatments or therapies."

Trial Locations (2)

20148

IRCCS S. Maria Nascente, Fondazione Don Carlo Gnocchi ONLUS, Milan

Unknown

IRCCS Don Gnocchi, Fondazione Don Carlo Gnocchi ONLUS, Florence

All Listed Sponsors
lead

Fondazione Don Carlo Gnocchi Onlus

OTHER

NCT05370105 - Extracellular Vesicles as Stroke Biomarkers | Biotech Hunter | Biotech Hunter